Anti-Infectives Study Experience

PPD ensures rapid study deployment across critical emerging markets for anti-infective and antifungal research. Our operations and regulatory experts are available to bring local knowledge of standards of care and regulations.

• PPD has managed clinical trials for anti-infectives across Europe, Latin America, the Middle East, North America and Southeast Asia
• Since 2000, PPD has conducted 37 Phase I-IV studies involving various antifungal drug classes, including invasive fungal infections, aspergillosis, candidiasis and cryptococcosis, with 6,800 patients and more than 630 sites.¹

With operations in key markets, we leverage our robust technical infrastructure to minimize the challenges of large-scale global research.

1. These numbers don't include our work in the government sector, which is tracked separately.